As of April 30, 2026, Izotropic Corp. carries a market capitalization of 21.96M, placing it among publicly traded companies globally. Its enterprise value stands at 24.85M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 21.96M |
| Enterprise Value | 24.85M |
As of April 30, 2026, Izotropic Corp. has 69.72M shares outstanding.
| Shares Outstanding | 69.72M |
These figures are as of April 30, 2026.
| PB Ratio | -3.90 |
| P/TBV Ratio | -3.90 |
| P/FCF Ratio | -23.71 |
| P/OCF Ratio | -23.71 |
As of April 30, 2026, Izotropic Corp. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -55.29, indicating conservative leverage, while an interest coverage ratio of -5.28 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.06 |
| Quick Ratio | 0.04 |
| Debt / Equity | -55.29 |
| Debt / EBITDA | -1.13 |
| Interest Coverage | -5.28 |
These figures cover the twelve months ended April 30, 2026. Return on assets (ROA) is negative at -683.53, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -683.53 |
As of the close on October 22, 2026, Izotropic Corp.'s stock has declined approximately 58.44% over the past 52 weeks. The 50-day moving average sits at 0.21, while the 200-day moving average is 0.24.
| 52-Week Price Change | -58.44% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.24 |
Over the twelve months ended April 30, 2026, Izotropic Corp. generated - - in revenue and converted that into -2.81M in net income, yielding earnings per share of -0.04. EBITDA reached -2.74M, while operating income came in at -2.49M.
| Operating Income | -2.49M |
| Pretax Income | -2.84M |
| Net Income | -2.81M |
| EBITDA | -2.74M |
| EBIT | -2.77M |
| Earnings Per Share (EPS) | -0.04 |
As of April 30, 2026, Izotropic Corp. holds 219,713.00 in cash and equivalents against 3.11M in total debt, resulting in a net debt position of 2.78M. Total book value stands at -5.63M, with working capital of -5.66M providing operational flexibility.
| Cash & Cash Equivalents | 219,713.00 |
| Total Debt | 3.11M |
| Net Debt | 2.78M |
| Equity (Book Value) | -5.63M |
| Book Value Per Share | -0.08 |
| Working Capital | -5.66M |
Izotropic Corp. produced -871,599.00 in operating cash flow over the twelve months ended April 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -871,599.00 - equivalent to -0.01 per share.
| Operating Cash Flow | -871,599.00 |
| Free Cash Flow | -871,599.00 |
| FCF Per Share | -0.01 |
Over the twelve months ended April 30, 2026, Izotropic Corp. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -4.22: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.90, meaning Izotropic Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -4.90 |
| FCF Yield | -4.22 |
As of April 30, 2026, Izotropic Corp. has an Altman Z-Score of -109.33, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -109.33 |
Already premium?